REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 2025 March 12, 2026 All economic indicators are positive. Consolidated turnover of €2,483.6 million (€2,300.5 million in 2024); EBITDA at €467.6 million (€410.6 million in 2024); EBIT at €391.7 million (€330.4 million in 2024) Group net profit at €250.9 million (€211.1 million in 2024) Approval of the proposed dividend distribution of €1.35 per share.
LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market March 12, 2026 LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step [...]
Fourth Appoints Veteran Product Leader Scott Collison as CEO March 12, 2026 Fourth, a leading provider of workforce and inventory management solutions for the hospitality industry, today announced the appointment of Scott Collison as Chief Executive Officer. A proven builder of enterprise software platforms with more than two decades of experience scaling technology companies, Collison will lead Fourth into its next phase of AI-led product innovation for [...]
Cryptio Raises $45m Series B as Digital Assets Move Into Regulated Financial Markets March 12, 2026 The system of record for tokenized finance – ERP infrastructure for institutions operating in digital assets
Waiv Secures $33 Million to Scale AI Precision Testing March 12, 2026 Waiv, a Paris-based startup, spins out of Owkin to accelerate AI-enabled precision oncology testing
Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets March 12, 2026 Newly combined company will focus on delivering technology-enabled client service and next-generation infrastructure to support the growth of private markets firms
Argan, Inc. to Announce Fourth Quarter and Fiscal Year-End 2026 Results and Host Conference Call on Thursday, March 26, 2026 March 12, 2026 Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2026 financial results after the market closes on Thursday, March 26, 2026. Management will host a webcast with an accompanying slide presentation and conference call on Thursday, March 26, 2026 at 5:00 p.m. ET. [...]
UK Fintech Legado Nears 500,000 Users as Financial Services Sector Rushes to Adopt More Digital Infrastructure March 12, 2026 Legado, which supports financial institutions in modernising customer communications and document management via its tech platform, counts FNZ, Quilter, Scottish Building Society, Moneyhub, and Co-op Legal Services among its client base
Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program March 12, 2026 — Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project — — Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings — — Application Period to Run From March 16, 2026 Through June 1, 2026 —
Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF) March 12, 2026 Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by complex and redundant biological pathways, limiting the effectiveness of single-target approaches. Baseimmune uses advanced computational protein design to target multiple pro-fibrotic pathways simultaneously. Initially focused on IPF, where approved single-target therapies only slow lung function decline. Fibrosis pipeline advancing toward proof-of-concept efficacy readouts in 2026 and 2027. Assembled world-class Scientific Advisory Board: John Cijiang He, Scott L. Friedman, Toby Maher, Paul Noble, and Joel Rurik.